Krystal Biotech (KRYS) Cash from Investing Activities (QoQ) (2017 - 2026)
Krystal Biotech (KRYS) Cash from Investing Activities (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Krystal Biotech | 9.84 Bn | 9.02 Bn | 110.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -669.59% |
| Dec 31, 2025 | 360.45% |
| Sep 30, 2025 | 59.28% |
| Jun 30, 2025 | 80.78% |
| Mar 31, 2025 | 34.63% |
| Dec 31, 2024 | -144.05% |
| Sep 30, 2024 | -77.38% |
| Jun 30, 2024 | 25.51% |
| Mar 31, 2024 | -155.71% |
| Dec 31, 2023 | -109.66% |
| Sep 30, 2023 | 759.22% |
| Jun 30, 2023 | -547.85% |
| Mar 31, 2023 | 168.41% |
| Dec 31, 2022 | 64.67% |
| Sep 30, 2022 | 61.43% |
| Jun 30, 2022 | 31.63% |
| Mar 31, 2022 | 55.82% |
| Dec 31, 2021 | -240.47% |
| Sep 30, 2021 | 40.36% |
| Jun 30, 2021 | -8,242.30% |